Shelby Gorman

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC

Helai P. Mohammad, Kimberly N. Smitheman, Chandrashekhar D. Kamat et al. · Cancer Cell · 2015 · 498 citations · Full text

Oncogenic Agent, Medicine, Epigenetic Change +9

Small and intermediate conductance Ca 2+ -activated K + channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum

Mao Xiang Chen, Shelby Gorman, Bill Benson et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 132 citations

Differential Cellular Localisation, Signal Transduction, Neurophysiology +14

METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

L.L. Siu, Drew Rasco, S. P. Vinay et al. · Annals of Oncology · 2019 · 130 citations · Full text

Molecular Biology, Advanced Solid Tumours, Anti-cancer Agent +6

Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity

Sujoy Ghosh, Robert Dent, Mary‐Ellen Harper et al. · BMC Medical Genomics · 2010 · 79 citations · Full text

“Z4” Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism

Hitoshi Shiota, Janine E. Elya, Artyom A. Alekseyenko et al. · Molecular Cancer Research · 2018 · 66 citations · Full text